Mesencephalic Astrocyte‐Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin‐Related Modifier (SUMO)ylation‐Related Suppression of NF‐κB/Snail Signaling Pathway and Epithelial‐Mesenchymal Transition

Background and Aims Endoplasmic reticulum (ER) stress is associated with liver inflammation and hepatocellular carcinoma (HCC). However, how ER stress links inflammation and HCC remains obscure. Mesencephalic astrocyte‐derived neurotrophic factor (MANF) is an ER stress‐inducible secretion protein th...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 71; no. 4; pp. 1262 - 1278
Main Authors Liu, Jun, Wu, Zhengsheng, Han, Dan, Wei, Chuansheng, Liang, Yanyan, Jiang, Tongcui, Chen, Lu, Sha, Manqi, Cao, Yajie, Huang, Fan, Geng, Xiaoping, Yu, Jishuang, Shen, Yujun, Wang, Hua, Feng, Lijie, Wang, Dong, Fang, Shengyun, Wang, Siying, Shen, Yuxian
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.04.2020
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN0270-9139
1527-3350
1527-3350
DOI10.1002/hep.30917

Cover

More Information
Summary:Background and Aims Endoplasmic reticulum (ER) stress is associated with liver inflammation and hepatocellular carcinoma (HCC). However, how ER stress links inflammation and HCC remains obscure. Mesencephalic astrocyte‐derived neurotrophic factor (MANF) is an ER stress‐inducible secretion protein that inhibits inflammation by interacting with the key subunit of nuclear factor kappa light chain enhancer of activated B cells (NF‐κB) p65. We hypothesized that MANF may play a key role in linking ER stress and inflammation in HCC. Approach and Results Here, we found that MANF mRNA and protein levels were lower in HCC tissues versus adjacent noncancer tissues. Patients with high levels of MANF had better relapse‐free survival and overall survival rates than those with low levels. MANF levels were also associated with the status of liver cirrhosis, advanced tumor‐node‐metastasis (TNM) stage, and tumor size. In vitro experiments revealed that MANF suppressed the migration and invasion of hepatoma cells. Hepatocyte‐specific deletion of MANF accelerated N‐nitrosodiethylamine (DEN)‐induced HCC by up‐regulating Snail1+2 levels and promoting epithelial‐mesenchymal transition (EMT). MANF appeared in the nuclei and was colocalized with p65 in HCC tissues and in tumor necrosis factor alpha (TNF‐α)‐treated hepatoma cells. The interaction of p65 and MANF was also confirmed by coimmunoprecipitation experiments. Consistently, knockdown of MANF up‐regulated NF‐κB downstream target genes TNF‐α, interleukin (IL)‐6 and IL‐1α expression in vitro and in vivo. Finally, small ubiquitin‐related modifier 1 (SUMO1) promoted MANF nuclear translocation and enhanced the interaction of MANF and p65. Mutation of p65 motifs for SUMOylation abolished the interaction of p65 and MANF. Conclusions MANF plays an important role in linking ER stress and liver inflammation by inhibiting the NF‐κB/Snail signal pathway in EMT and HCC progression. Therefore, MANF may be a cancer suppressor and a potential therapeutic target for HCC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this article.
Supported by grants from the Natural Science Foundation of China (81372576 and 81673438 to Yuxian Shen and 81602120 to Jun Liu) and the Natural Science Foundation of Anhui Province (1708085QH176 to Jun Liu).
Potential conflict of interest: Nothing to report.
Correction added on February 17, 2020, after first online publication: The corresponding author email was corrected.
ISSN:0270-9139
1527-3350
1527-3350
DOI:10.1002/hep.30917